SCHEMBL4334182

SCHEMBL4334182

CC(C)OC(Cc1ccccc1COC(=O)Nc1ccc(C(F)(F)F)cc1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.45
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
FPR2 P25090 1/20 0.43
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
PPARD Q03181 1/20 0.41
KCNJ5 P48544 1/20 0.41
KCNJ3 P48549 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
LDHA P00338 1/20 0.40
LDHB P07195 1/20 0.40
MTOR P42345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329791 0.89 LMNA (0.44) MGLLRAB9ANPC1MEN1KMT2A
SCHEMBL4348521 0.89 MGLL (0.48) MGLLRAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL4335538 0.88 KMT2A (0.45) MGLLRAB9ANPC1MEN1KMT2A
SCHEMBL4335130 0.88 FPR2 (0.47) RAB9ANPC1FPR2PPARGPPARA
SCHEMBL4341658 0.87 MAPT (0.48) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL4327192 0.86 CYP1A2 (0.56) RAB9ANPC1PPARGPPARAMEN1
SCHEMBL4347142 0.85 MEN1 (0.52) MGLLFPR2PPARGPPARAPPARD
SCHEMBL4335160 0.85 LMNA (0.48) RAB9ANPC1FPR2PPARGPPARA
SCHEMBL4334181 0.85 MEN1 (0.52) MGLLFPR2PPARGPPARAPPARD
SCHEMBL6727481 0.84 MAPT (0.47) RAB9ANPC1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MGLL 3539/4885RAB9A 2956/4885NPC1 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.